< 1 minute read
Oct. 6, 2021
MK-8262: A CETP Inhibitor
MK-8262
potential best-in-class CETP inh. (<1 mg QD) completed Ph. I in HV; discont. as backup from anacetrapib Journal of Medicinal Chemistry Merck & Co., Kenilworth, NJ, USA
Loading...
potential best-in-class CETP inh. (<1 mg QD) completed Ph. I in HV; discont. as backup from anacetrapib Journal of Medicinal Chemistry Merck & Co., Kenilworth, NJ, USA